郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis.

期刊：The Journal of antibiotics发表年份：2016作者：Shasha Rao; Clive A Prestidge; Lynn Miesel; Deb Sweeney; Dean L Shinabarger; Ramiz A Boulos
阅读更多 →

药效评价Protective inflammatory response against visceral leishmaniasis with potato tuber extract: A new approach of successful therapy.

期刊：Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie发表年份：2016作者：Dibyendu Paik; Partha Das; Kshudiram Naskar; Pijush Kanti Pramanik; Tapati Chakraborti
阅读更多 →

药效评价Angiotensin II analogues with N-terminal lactam bridge cyclization: an overview on AT1 receptor activation and tachyphylaxis.

期刊：Chemical biology & drug design发表年份：2016作者：Flávio Lopes Alves; Vani Xavier Oliveira; Antonio Miranda
阅读更多 →

药效评价Discovery of novel 2',4'-dimethyl-[4,5'-bithiazol]-2-yl amino derivatives as orally bioavailable TRPV4 antagonists for the treatment of pain: Part 2.

期刊：Bioorganic & medicinal chemistry letters发表年份：2016作者：Naoki Tsuno; Akira Yukimasa; Osamu Yoshida; Shinji Suzuki; Hiromi Nakai; Tomoyuki Ogawa; Motohiro Fujiu; Kenji Takaya; Azusa Nozu; Hiroki Yamaguchi; Hidetoshi Matsuda; Satoko Funaki; Yoko Nishimura; Tetsuji Ito; Daiki Nagamatsu; Toshiyuki Asaki; Naru
阅读更多 →